Knight Therapeutics (OTCMKTS:KHTRF) Rating Reiterated by Raymond James  Modern Readers

Knight Therapeutics (OTCMKTS:KHTRF)’s stock had its “buy” rating restated by analysts at Raymond James in a research note issued to investors on …